AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Report Evaluates Emerging Therapies.(Brief Article)
2002 FEB 20 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., announces the publication of "Pancreatic Cancer," a new study that evaluates the current status of, and future prospects for, therapies to treat this highly virulent cancer.
Pancreatic cancer (PC) is a biologically complex disease that is highly resistant to treatment. For more than 80% of patients with pancreatic cancer, no effective treatment exists, and few patients with advanced stage disease are alive after one year. Therefore, any well-tolerated, efficacious therapy would encounter few obstacles on its way to market penetration.
Experts contacted by Decision Resources consider therapeutic vaccines and epidermal growth factor (EGF) inhibitors, particularly receptor tyrosine kinase inhibitors, to be the most promising approaches now under investigation.
Therapeutic vaccines and EGF inhibitors are being evaluated in Phase III trials. Decision Resources (DR) believes that these trials will show that these agents improve survival rates and carry very little toxicity, and DR thus anticipates that they will, upon approval, rapidly become ...
- Benefits of Current Therapeutic Options for Pancreatic Cancer are Eclipsed by...
- Press release article from: PR Newswire June 14, 2004 700+ words
...PRNewswire/ -- Decision Resources, Inc., one...the launch of therapeutic vaccines such as Aphton...analyst at Decision Resources. "This use of...Pharmacor from Decision Resources Pharmacor is a...
- Genentech/Roche's Herceptin is a Promising Therapy for Pancreatic Cancer,...
- Press release article from: PR Newswire February 19, 2002 700+ words
...overexpress HER-1. Decision Resources anticipates...agent therapy. Therapeutic Vaccines Among the therapeutic vaccines in development...low toxicity, Decision Resources anticipates that therapeutic vaccines would be used...
- Will therapeutic vaccines, which have had setbacks, fulfil their promise?
- Newspaper article from: Pharma Marketletter January 30, 2006 700+ words
Therapeutic vaccines have faced numerous setbacks...vaccines dominate the pipeline Therapeutic vaccines are defined as medications that...fact, the analysis shows that therapeutic vaccines development is currently heavily...
- Research and Markets: Therapeutic Vaccines.
- Press release article from: Business Wire August 26, 2004 700+ words
...Ireland -- The Worldwide Market for Therapeutic Vaccines is Estimated to Be $80M in 2004...has announced the addition of Therapeutic Vaccines to their offering. With the worldwide...patients. The worldwide market for therapeutic vaccines is estimated to be$80M in 2004...
- Building Better Therapeutic Vaccines for Chronic Infections:Study Finds Poor T...
- News wire article from: AScribe Health News Service July 1, 2005 700+ words
...increasingly interested in developing therapeutic vaccines. Most Americans are familiar with...vaccines as well as the flu shot. But therapeutic vaccines are designed instead to be administered...such as HIV or hepatitis. These therapeutic vaccines aim to enhance the immune system...
- Therapeutic vaccines target HPV.(Cervical cancer)(Human Papilloma Virus)
- Magazine article from: Chemistry and Industry Carmichael, Helen August 13, 2007 700+ words
...cancer experts say. But progress in therapeutic vaccines offers hope to women with early...some strains of HPV. Meanwhile, therapeutic vaccines would most likely be marketed to...be worth 400-700m [euro]. 'Therapeutic vaccines would represent a very small slice...
- Businessinfo.ws: Therapeutic Vaccines to Be Worth USD 4.3 Bn In 2010.
- Press release article from: Business Wire March 22, 2005 700+ words
...the total global market for therapeutic vaccines was USD 8.1 million in 2004...products easier. However, with therapeutic vaccines, especially those for treating...Because of the innovative nature of therapeutic vaccines, they will be very high-ticket...
- Role of therapeutic vaccines for the control of HIV-1 reviewed.
- Newspaper article from: Biotech Week June 2, 2004 700+ words
...Scientists review the role of therapeutic vaccines for the control of HIV-1 in a...the potential role for HIV-1 therapeutic vaccines in the era of HAART will be discussed...Antimicrobial Chemotherapy (Role of therapeutic vaccines in the control of HIV-1. J Antimicrob...
- Oxxon completes 15m [pounds sterling] round to fund therapeutic vaccines.
- Newspaper article from: BioWorld International Moran, Nuala April 16, 2003 700+ words
...Oxxon Pharmaccines Ltd., a therapeutic vaccines specialist, reached the upper limit...recognition of the commercial potential of therapeutic vaccines, where the technology is maturing...are now focused on driving our two therapeutic vaccines products to proof of clinical efficacy...
- Research and Markets: For the Current Trends and Market Forecast on Therapeutic...
- Press release article from: PR Newswire April 27, 2005 700+ words
...has announced the addition of Therapeutic Vaccines for Cancer: On the Threshold of...Question: Which of the following therapeutic vaccines currently in Phase III do you think...succeed? Projected U.S. Market for Therapeutic Vaccines For more information visit http...
Source: HighBeam Research, Report Evaluates Emerging Therapies.(Brief Article)